Cboe BZX · CBRG
Leverage Shares 2X Long CBRS Daily ETF financials
$3.28−1.35%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 |
| Gross margin | — | — |
| Operating income | -$1.3M | -$1.4M |
| Net income | $7.6M | $8.6M |
| Net margin | — | — |
| Diluted EPS | $0.45 | $0.37 |
| EBITDA | -$1.3M | -$1.4M |
| Operating cash flow | -$935.7K | -$904.3K |
| Free cash flow | -$935.7K | — |
| Diluted shares | 17.0M | 23.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Cash & equivalents | $3.9K | $116.3K | $740.6K |
| Short-term investments | $0.00 | $0.00 | — |
| Total debt | $0.00 | $1.4M | $0.00 |
| Total assets | $45.4M | $238.2M | $236.2M |
| Total liabilities | $186.8K | $4.3M | $12.9M |
| Shareholders' equity | -$79.8K | -$3.7M | -$11.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology